191 related articles for article (PubMed ID: 32196579)
1. LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer.
Wang ZH; Wang JH; Wang KQ; Zhou Y; Wang J
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2281-2293. PubMed ID: 32196579
[TBL] [Abstract][Full Text] [Related]
2. LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer.
Wang ZH; Wang JH; Wang KQ; Zhou Y; Wang J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8250. PubMed ID: 32894530
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FEZF1-AS1 promotes colorectal cancer progression through regulating the miR-363-3p/PRRX1 pathway.
Zhang T; Yu S; Zhao S
Adv Clin Exp Med; 2021 Aug; 30(8):839-848. PubMed ID: 34286520
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2.
Hui Y; Yang Y; Li D; Wang J; Di M; Zhang S; Wang S
Cell Transplant; 2020; 29():963689720925059. PubMed ID: 32638620
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA FEZF1-AS1 Modulates CXCR4 to Promote Cell Proliferation, Warburg Effect and Suppress Cell Apoptosis in Osteosarcoma by Sponging miR-144.
Liu J; Feng G; Li Z; Li R; Xia P
Onco Targets Ther; 2020; 13():2899-2910. PubMed ID: 32308422
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FEZF1-AS1 Promotes Multi-Drug Resistance of Gastric Cancer Cells via Upregulating ATG5.
Gui Z; Zhao Z; Sun Q; Shao G; Huang J; Zhao W; Kuang Y
Front Cell Dev Biol; 2021; 9():749129. PubMed ID: 34790665
[TBL] [Abstract][Full Text] [Related]
9. lncRNA FEZF1-AS1 regulates biological behaviors of cervical cancer by targeting miRNA-1254.
Liang M; Li Y; Dai T; Chen C
Food Sci Nutr; 2021 Sep; 9(9):4722-4737. PubMed ID: 34531986
[TBL] [Abstract][Full Text] [Related]
10. Constructed the ceRNA network and predicted a FEZF1-AS1/miR-92b-3p/ZIC5 axis in colon cancer.
Yang X; Wu P; Wang Z; Su X; Wu Z; Ma X; Wu F; Zhang D
Mol Cell Biochem; 2023 May; 478(5):1083-1097. PubMed ID: 36219353
[TBL] [Abstract][Full Text] [Related]
11. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
12. Long Non-coding RNA FEZF1-AS1 Promotes Growth and Reduces Apoptosis Through Regulation of miR-363-3p/PAX6 Axis in Retinoblastoma.
Liu X; Li X; Li J
Biochem Genet; 2021 Jun; 59(3):637-651. PubMed ID: 33432525
[TBL] [Abstract][Full Text] [Related]
13. ATF2-Induced lncRNA GAS8-AS1 Promotes Autophagy of Thyroid Cancer Cells by Targeting the miR-187-3p/ATG5 and miR-1343-3p/ATG7 Axes.
Qin Y; Sun W; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang H
Mol Ther Nucleic Acids; 2020 Dec; 22():584-600. PubMed ID: 33230459
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial-mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis.
He J; Xi X; Cao P; Zhou J; Liu H; Li N
Open Med (Wars); 2023; 18(1):20230740. PubMed ID: 37465347
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of circ_0037655 impedes glioma formation and metastasis via the regulation of miR-1229-3p/ITGB8 axis.
Zou W; Cao Y; Cheng K; Li C; Zhu F; Yang S; Jin M; Song S
Open Life Sci; 2021; 16(1):442-454. PubMed ID: 34017919
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FEZF1-AS1 accelerates the migration and invasion of laryngeal squamous cell carcinoma cells through miR-4497 targeting GBX2.
Chen X; Cheng P; Hu C
Eur Arch Otorhinolaryngol; 2021 May; 278(5):1523-1535. PubMed ID: 33550476
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
19. LncRNA DHRS4-AS1 Inhibits the Stemness of NSCLC Cells by Sponging miR-224-3p and Upregulating TP53 and TET1.
Yan F; Zhao W; Xu X; Li C; Li X; Liu S; Shi L; Wu Y
Front Cell Dev Biol; 2020; 8():585251. PubMed ID: 33425890
[TBL] [Abstract][Full Text] [Related]
20. Long-non-coding RNA RUSC1-AS1 accelerates osteosarcoma development by miR-101-3p-mediated Notch1 signalling pathway.
Jiang R; Zhang Z; Zhong Z; Zhang C
J Bone Oncol; 2021 Oct; 30():100382. PubMed ID: 34367901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
